(S)-1-(Pyridin-2-yl)ethanamine dihydrochloride, 95.0%, 10g

6-Methyl-5,6,7,8-tetrahydro-pyrido[4,3-d]pyrimidin-2-ylamine, 96%, 100mg

2-(2-(2-(2-((Tetrahydro-2H-pyran-2-yl)oxy)ethoxy)ethoxy)ethoxy)ethyl 4-methylbenzenesulfonate, 97%, 500mg

2-(5-Chloro-2-fluoro-3-methylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95%, 1g

N-Cyanoacetylurethane, 95.0%, 10g

tert-Butyl(3-iodopropoxy)dimethylsilane, 97%, 5g

2-(2,6-Dimethylcyclohex-1-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98+%, 250mg

Methyl 2-[4-(trifluoromethoxy)phenoxy]acetate, 1g

[3-(pyridin-4-yl)-1,2,4-oxadiazol-5-yl]methanamine, 95.0%, 250mg

Methanol 60 %, 60 %, zur Synthese, 25 l, kunststoffverpackung.

Cyclohex-3-enyl-carbamic acid tert-butyl ester, 98%, 250mg

Bis((R)-4-benzyl-4,5-dihydrooxazol-2-yl)methane, 95.0%, 250mg

4-Benzyl-1-oxa-4,9-diazaspiro[5.5]undecan-3-one, 95.0%, 100mg